These findings will be published in an upcoming issue of JACC, the Journal of the American College of Cardiology.
Under-Referral of Women for Atrial Fibrillation Ablation: Can This Be Explained by Gender Differences in Outcome?
Andrea M. Russo, MD, Electrophysiology Laboratory Director and Clinical Associate Professor of Medicine
10 a.m., Sunday, March 30
Dr. Russo and her colleagues from the division of cardiovascular medicine at Penn will present research on disparities in treatment of women suffering atrial fibrillation, one of the most common abnormal heart rhythms.
Although women represent more than half of patients with this serious rhythm problem, they are less likely to be referred for atrial fibrillation ablation a therapy that uses radiofrequency energy to cauterize the heart tissue around each pulmonary vein to keep abnormal electrical signals from reaching the rest of the heart and triggering the faulty rhythm than men.
Russo studied 1,165 women and men who underwent ablation at Penn and found that both groups had similar arrhythmia control at 24 months after the procedure (84 percent of women and 89 percent of men), suggesting that more women should be referred for ablation therapy.
Women Face Higher Risk for Decline in Left Ventricular Ejection Fraction Following Orthotopic Liver Transplant
James N. Kirkpatrick, MD, Assistant Professor of Medicine
10 a.m., Tuesday, April 1
Chronic liver disease patients often have low systemic vascular resistance that causes low blood pressure before liver transplant, but after receiving a new liver, they may suffer post-operative heart problems that leave the left ventricle unable to pump out an adequate amount of blood. This situation puts patients at a greater risk of organ failure and death.
Dr. Kirkpatrick and his colleagues studied 80 patients who received an orthotopic
|Contact: Holly Auer|
University of Pennsylvania School of Medicine